​​​
  1. EU ban on GVK Bio to hit exports worth $1.23 billion

EU ban on GVK Bio to hit exports worth $1.23 billion

The recent ban on GVK Bio by the European Union (EU) is expected to hit exports from India worth $1.23 billion, according to PV Appaji...

By: | Published: July 28, 2015 12:35 AM

The recent ban on GVK Bio by the European Union (EU) is expected to hit exports from India worth $1.23 billion, according to PV Appaji, director general, Pharmaceutical Export Promotion Council of India (Pharmexil). This is for the first time that exports to EU is showing a negative growth.

The EU has banned marketing of around 700 generic medicines for alleged manipulation of clinical trials conducted by GVK Bio. GVK Bio has been conducting human trials of generic drugs on behalf of globally-operating companies.

Get live Stock Prices from BSE and NSE and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Go to Top